Genetic biomarker linked to improved survival for patients with certain brain tumors
A DNA-level biomarker (MGMT promoter methylation) can be used to help predict survival outcomes in patients with high-risk, low-grade gliomas, according to a new study conducted through the NRG Oncology/RTOG collaborative ...
Jun 28, 2018
0
67